Original Article

A clinical profile of patients with Parkinson’s disease and psychosis B. R. Amar, Ravi Yadav, Y. C. Janardhan Reddy1, Pramod Kumar Pal Departments of Neurology and 1Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India Abstract Aims: The aim of the study was to study the clinical profile of the patients with Parkinson’s disease (PD) and psychosis. Settings and Design: This was a prospective, cross sectional, hospital-based study done at the Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India from September 2009 to January 2011. All patients with PD, diagnosed by United Kingdom PD Society Brain Bank criteria, having with features of psychosis as diagnosed by the neuropsychiatric inventory (NPI) were included. Patients without a caregiver who could validate the patient’s symptoms were excluded. Results: A total of 40 patients (5 women, 35 men) with PD with psychosis (mean age: 54.2 ± 11.5 years, mean duration of illness: 6.5 ± 4.5 years, and mean duration of psychosis: 4.3 ± 4.3 years) were included in the study. The Global NPI score was 19.1 ± 11.5. Majority of the patients had pure hallucinations (85%), while the rest had either pure delusions (7.5%) or a combination of delusions and hallucinations (7.5%). In those with hallucinations, visual hallucinations were the commonest (60%) (pure only in 22.5%), followed by auditory (45%), minor hallucinations (45%), and tactile (20%). Only one person reported having olfactory hallucinations (2.5%). Loss of insight was most often observed during the visual hallucinations (52%), followed by tactile (44.4%), auditory (38.9 %), and minor hallucinations (33.3%). Conclusions: In patients with PD and psychosis, pure hallucinations are common and visual hallucinations are the commonest among the hallucinations. A large proportion of patients have minor hallucinations, which need to be recognized early for effective and early management. The limitations of the study were small sample size, use of a single scale to assess psychosis and subjective assessment of insight.

Key Words Delusions, hallucinations, NPI, PD, psychosis For correspondence: Dr. Pramod Kumar Pal, Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS),

Hosur Road, Bangalore - 560 029, Karnataka, India. E-mail: [email protected] Ann Indian Acad Neurol 2014;17:187-92

Introduction

and prognosis of the disease and are important risk factors for nursing home placement and mortality of PD.[3,4]

Parkinson’s disease (PD) is one of the commonest movement disorders in the world.[1] In spite of PD being a predominantly motor disorder, majority of patients develop a variety of non-motor manifestations. The most challenging nonmotor symptom is psychosis. The clinical spectrum of psychosis in PD includes visual hallucinations with or without retained insight, other hallucinations (auditory, tactile, olfactory, and minor hallucinatory phenomena) and delusions.[2] These psychotic symptoms have a major impact on the natural course Access this article online Quick Response Code:

Website: www.annalsofian.org

DOI: 10.4103/0972-2327.132625

The prevalence of the psychotic symptoms have varied largely in most studies, mostly owing to a lack of uniform definition of psychosis, lack of disease-specific scales to measure psychosis, and also use of scales that are not validated to measure psychotic symptoms.[5-7] In addition, there are only limited data on the pa ern of psychosis in PD, especially from India.[8] Therefore, the present study was undertaken to study the clinical profile of the patients with Parkinson’s disease and psychosis using the neuropsychiatric inventory (NPI) for rating of psychotic symptoms. Although various scales have been used to assess psychosis in PD,[9-11] the NPI is a well-validated scale to screen for various psychotic symptoms in PD.[12]

Materials and Methods This prospective, cross-sectional, hospital-based study was conducted at the Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, Annals of Indian Academy of Neurology, April-June 2014, Vol 17, Issue 2

188

Amar, et al.: Psychosis in PD

India from September 2009 to January 2011. The study was approved by the institute’s ethics commi ee and all the patients and their caregivers who were interviewed gave written informed consent. A diagnosis of PD was made according to the United Kingdom PD Society (UKPDS) Brain Bank criteria for PD[13] and all patients were evaluated by the UPDRS-part III (motor part) scale,[13] Hoehn and Yahr staging, the NPI,[12] the mini mental status examination (MMSE) score for cognitive screening.

Results

The NPI evaluates 12 neuropsychiatric domains: delusions, hallucinations, agitation, depression, anxiety, apathy, irritability, euphoria, disinhibition, aberrant night time behavior, night time behavior, and appetite change. The frequency, severity, and distress of each domain is rated on the basis of scripted questions administered to the patient’s caregiver. The product of frequency and severity of each domain and the total NPI score was calculated in all patients. The test-retest variability, interrater variability has been already established.[12] The patients were diagnosed to have psychosis based on diagnostic criteria for psychosis in PD.[14] The diagnosis of PD associated psychosis was made in a case of PD with symptoms starting a er the onset of PD with the presence of at least one of the following symptoms (1) illusions, (2) false sense of presence, (3) hallucinations, and (4) delusions. The symptoms should last for at least 1 month and the other mimickers should be excluded.[14] The patients who were excluded were those as per UKPDS brain bank criteria, those who were unwilling to participate in the study or did not cooperate for the interview and those without a caregiver who could validate the history of patient’s symptoms. The patients with cognitive deficits were not excluded.

Characteristics of psychosis The mean duration of psychotic symptoms (hallucinations/ delusions) was 4.34 ± 4.26 years. The psychotic symptoms included pure hallucinations in 34 patients (85%), pure delusions in 3 patients (7.5%), and a combination of delusions and hallucinations in 3 patients (7.5%) [Tables 3-6]. Visual hallucinations were the commonest type of hallucinations, followed by other hallucinations, such as auditory, minor, tactile, and olfactory [Table 5]. Majority of the patients had a mixed type of hallucinations (45%). Nine (22.5%) had pure visual hallucinations, five (12.5%) had pure auditory, and only two patients (5%) had minor hallucinations. A combination

A predesigned proforma was used to record comprehensively all the information pertaining to PD and the psychotic symptoms. Hallucinations, when present, were classified into visual, auditory, tactile, olfactory, minor, or mixed. Further characterization of hallucinations included frequency, threatening or nonthreatening, presence or absence of insight, time of occurrence, and so on. All effort was made to collect accurate information of the past and current medications for Parkinsonian symptoms as well for other disorders, if any. Details of anti-Parkinsonian drugs, especially dosage, duration of treatment, and temporal association between medications and onset of psychosis were ascertained. The total levodopa equivalent dosage (TLED) was calculated a er converting all drug dosages patients were currently taking into their levodopa equivalent dosages.[15] These were then added up and the mean TLED calculated. Statistical analysis Statistical analysis was done using SPSS 16.0 package. Data were expressed using descriptive statistics, that is, mean, standard deviation (SD) for continuous variables and frequency, percentages for categorical variables. Comparisons between groups were done using independent Student’s t-test for continuous variables and chi-square test for categorical variables. Correlation between continuous variables was done using Pearson’s correlation coefficient. A P < 0.05 was considered statistically significant. Annals of Indian Academy of Neurology, April-June 2014, Vol 17, Issue 2

A total of 40 patients were recruited for this study. The mean TLED was 683.36 ± 404.33 mg/day [Table 1]. Majority of the patients had prior use of anticholinergics (62.5%), followed by use of dopamine agonists (47.5%), levodopa (35%), and amantadine (35%). Approximately, 15% of patients had prior exposure to antipsychotics [Table 2]. Six patients had an MMSE

A clinical profile of patients with Parkinson's disease and psychosis.

The aim of the study was to study the clinical profile of the patients with Parkinson's disease (PD) and psychosis...
394KB Sizes 1 Downloads 3 Views

Recommend Documents


Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases.
Glycogen storage disease type III (GSDIII) is a rare autosomal recessive disorder due to glycogen debranching enzyme (GDE) deficiency. It results in a multisystemic disease with predominant hepatic and myopathic symptoms. While frequent social maladj

Investigation of Motor Cortical Plasticity and Corticospinal Tract Diffusion Tensor Imaging in Patients with Parkinsons Disease and Essential Tremor.
Parkinson's disease (PD) and essential tremor (ET) are characterized with motor dysfunctions. Motor circuit dysfunctions can be complementarily investigated by paired associative stimulation (PAS)-induced long-term potentiation (LTP)-like plasticity

Clinical and epidemiological profile of patients with valvular heart disease admitted to the emergency department.
To evaluate the clinical and epidemiological profile of patients with valvular heart disease who arrived decompensated at the emergency department of a university hospital in Brazil.

Cognitive correlates of psychosis in patients with Parkinson's disease.
Psychosis and hallucinations occur in 20-30% of patients with Parkinson's disease (PD). In the current study, we investigate cognitive functions in relation to the occurrence of psychosis in PD patients.

Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients.
Reduced verbal fluency (VF) has been reported in patients with Parkinson's disease (PD), especially those treated by Deep Brain Stimulation of the subthalamic nucleus (STN DBS). To delineate the nature of this dysfunction we aimed at identifying the

Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study.
To evaluate the association between the premotor symptoms and the prognosis of PD.

Acute Psychosis as Major Clinical Presentation of Legionnaires' Disease.
We report a case of a 61-year-old woman who presented with acute psychosis as a major manifestation of Legionnaires' disease in the absence of other neuropsychiatric symptoms. Clinical history revealed dry cough and nausea. Observation showed fever a

Clinical profile of patients with nascent alcohol related seizures.
The aim of this study is to characterize the clinical profile of patients with alcohol related seizures (ARS) and to identify the prevalence of idiopathic generalized epilepsy (IGE) in the same.

Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy.
Although tako-tsubo cardiomyopathy (TTC) is regarded as a reversible condition with favorable outcome, a malignant clinical course evolves in some subjects. In this single-institution experience, we describe the clinical profile of patients with adve

Clinical profile of cutaneous manifestations with and without hematologic disease: A comparative study.
The aim was to study the clinical profile of cutaneous manifestations of hematologic disorders and to compare it with that of non-hematologic disorders.